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Abstract
In eukaryotes, intracellular cholesterol homeostasis and trafficking are tightly regulated. Certain bacteria, such as Anaplasma
phagocytophilum, also require cholesterol; it is unknown, however, how this cholesterol-dependent obligatory intracellular
bacterium of granulocytes interacts with the host cell cholesterol regulatory pathway to acquire cholesterol. Here, we report
that total host cell cholesterol increased .2-fold during A. phagocytophilum infection in a human promyelocytic leukemia
cell line. Cellular free cholesterol was enriched in A. phagocytophilum inclusions as detected by filipin staining. We
determined that A. phagocytophilum requires cholesterol derived from low-density lipoprotein (LDL), because its replication
was significantly inhibited by depleting the growth medium of cholesterol-containing lipoproteins, by blocking LDL uptake
with a monoclonal antibody against LDL receptor (LDLR), or by treating the host cells with inhibitors that block LDL-derived
cholesterol egress from late endosomes or lysosomes. However, de novo cholesterol biosynthesis is not required, since
inhibition of the biosynthesis pathway did not inhibit A. phagocytophilum infection. The uptake of fluorescence-labeled LDL
was enhanced in infected cells, and LDLR expression was up-regulated at both the mRNA and protein levels. A.
phagocytophilum infection stabilized LDLR mRNA through the 39 UTR region, but not through activation of the sterol
regulatory element binding proteins. Extracellular signal–regulated kinase (ERK) was up-regulated by A. phagocytophilum
infection, and inhibition of its upstream kinase, MEK, by a specific inhibitor or siRNA knockdown, reduced A.
phagocytophilum infection. Up-regulation of LDLR mRNA by A. phagocytophilum was also inhibited by the MEK inhibitor;
however, it was unclear whether ERK activation is required for LDLR mRNA up-regulation by A. phagocytophilum. These data
reveal that A. phagocytophilum exploits the host LDL uptake pathway and LDLR mRNA regulatory system to accumulate
cholesterol in inclusions to facilitate its replication.
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Introduction
Cholesterol is an important component of biological mem-
branes, and it is essential for many biological functions ranging
from membrane trafficking to signal transduction in eukaryotic
cells [1]. However, excess cholesterol must be avoided in cells as
well as in the blood stream, because it alters intracellular vesicular
trafficking, deregulates cellular signaling, and initiates atheroscle-
rosis [2,3]. The liver in large part regulates blood cholesterol levels
by removing it from circulating blood. To maintain cellular
cholesterol levels within a specified range, cholesterol levels are
constantly assessed and tightly regulated in a complex manner at
the transcriptional, translational, and posttranslational levels [4].
In recent years, cellular cholesterol has emerged as a significant
factor, which influences outcome of infectious diseases from
microbiological and cell biological studies. The cholesterol content
of host cell membranes appears to be critical for microbial entry,
intracellular localization, and exit by exocytosis [5]. A growing
body of evidence suggests that host cellular cholesterol levels affect
the replication of intracellular microbial pathogens, such as
Salmonella, Mycobacterium, Brucella, and Coxiella [5,6,7], but how
cholesterol influences replication of these pathogens are not
completely understood. Among the above-mentioned pathogens,
infection by Salmonella or Coxiella up-regulates cellular cholesterol
levels, although the mechanisms of up-regulation are not clear
[7,8]. One of the common characteristics for these intracellular
bacteria is that after internalization into their host cells the bacteria
reside and proliferate in parasitophorous vacuoles. As such,
cholesterol may play a role in nutrient acquisition by bacteria
entrapped within vacuoles, or the accumulation of cholesterol may
prevent phagolysosomal fusion [5].
Anaplasma phagocytophilum is a tick-borne obligatory intracellular
bacterium that proliferates in membrane-bound inclusions in
granulocytes and endothelial cells of various mammal species
[9,10,11]. In humans, A. phagocytophilum causes an emerging and
major tick-borne disease called human granulocytic anaplasmosis,
an acute febrile disease that is potentially fatal, especially in elderly
or immunocompromised individuals [12]. A. phagocytophilum is an
atypical Gram-negative bacterium, because it contains substantial
amounts of cholesterol in its outer membrane [13]. The bacterium
lacks genes for cholesterol biosynthesis or modification; rather, it
directly acquires cholesterol from its host cells or the medium [13].
Our previous data showed that cholesterol is required for A.
phagocytophilum proliferation in host human promyelocytic leukemia
HL-60 cells and that a high blood cholesterol level facilitates A.
phagocytophilum infection in a mouse model [13,14]. A. phagocytophi-
lum enters host cells through caveolae or lipid rafts, and the
inclusion membrane retains caveolin-1 throughout infection,
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growing bacterial inclusions [15].
Considering cholesterol-dependence of A. phagocytophilum mem-
brane integrity and the importance of cholesterol for the infection
process, thus survival [13], we questioned how host cellular
cholesterol uptake, trafficking, and regulatory systems are involved
in A. phagocytophilum infection of human leukocytes. In this study,
we present data on the intracellular cholesterol level and
cholesterol distribution in A. phagocytophilum–infected HL-60 cells.
We provide evidence that the source of increased level of cellular
cholesterol required for A. phagocytophilum replication is extracellu-
lar low-density lipoprotein (LDL) rather than cholesterol synthe-
sized by the host cells. Finally, we propose a mechanism by which
the cellular LDL receptor (LDLR) level is increased in infected
HL-60 cells to take up more LDL. The data underscore an
important evolutionary adaptation of A. phagocytophilum to hijack
host cell cholesterol.
Results
Total cholesterol level is up-regulated in A.
phagocytophilum–infected cells
We previously measured the total cholesterol level of host cell–
free A. phagocytophilum and found that the level of total cholesterol
per milligram of protein was higher than that of host cells [13].
Here, we further measured the total cholesterol level in A.
phagocytophilum–infected HL-60 cells following infection time
course. The total cellular cholesterol level progressively increased
at days 2 and 3 post-infection (p.i.), and the level was significantly
greater than that at day 0 p.i. (after 1 h incubation at 37uC). The
increase in cholesterol level in infected HL-60 cells correlated with
bacterial growth (Figure 1). In contrast, the cholesterol level in
uninfected HL-60 cells remained unchanged during the same
observation period (data not shown).
Free cholesterol is enriched in A. phagocytophilum
inclusions
Most of the free (unesterified) cholesterol in eukaryotic cells is
located in the plasma membrane [16]. Over-accumulation of free
cholesterol in cells can be toxic due to the potential formation of
solid crystals [17]. To determine the intracellular distribution of
the observed increased cholesterol in A. phagocytophilum–infected
HL-60 cells, we used a polyene antibiotic, filipin, which binds
specifically to free cholesterol [18]. A specific antibody against A.
phagocytophilum was used to localize bacteria by double immuno-
fluorescence microscopy. First, the microscopy analysis clearly
showed the overall filipin signal was much stronger in A.
phagocytophilum-infected HL-60 cells than that in uninfected HL-
60, which supports the data shown in Figure 1 and further suggests
the increased total cellular cholesterol might be free cholesterol,
but not esterified cholesterol (Figure 2A). Second, most of the
filipin signal was confined in A. phagocytophilum–containing vacuoles
(‘‘inclusions’’) (Figure 2A). Uninfected host cells showed weak
filipin signal, which was mostly localized to the plasma membrane
and some unknown compartments (assumed to be recycling
endocytic compartments [19]). Notably, A. phagocytophilum inclu-
sions outside of host cells also clearly displayed strong filipin signals
(Figure 2B), suggesting that the inclusion has intrinsic ability to
retain the cholesterol. Recently, it was shown that Chlamydia
release from the infected host cells occurs by two mechanisms: lysis
and extrusion [20]. How the A. phagocytophilum inclusion became
extracellular remains to be studied. Taken together, these results
indicate that A. phagocytophilum infection alters host intracellular
cholesterol homeostasis and distribution and that free cholesterol is
enriched in A. phagocytophilum inclusions.
A. phagocytophilum infection requires cholesterol
derived from the host LDL uptake pathway rather than
de novo biosynthesis
Mammalian cells acquire cholesterol from two sources:
receptor-mediated uptake from exogenous lipoproteins and
endogenous biosynthesis in the smooth ER [4]. In leukocytes,
LDL is the primary exogenous cholesterol source that is acquired
via LDLR-mediated endocytosis [21]. After hydrolysis of choles-
Figure 1. Total cholesterol level is increased in A. phagocyto-
philum–infected HL-60 cells. A. phagocytophilum–infected HL-60
cells were harvested on 0, 1, 2 and 3 day p.i., and total cellular
cholesterol levels and bacterial burden were determined. Cholesterol
concentrations are expressed as micrograms of total cholesterol
(esterified and unesterified cholesterol) per milligram of total protein
(black triangles). Bacterial burdens are expressed as bacterial numbers
per 100 cells (black bars). Data are expressed as mean6standard
deviation (n=3) and are representative of at least three independent
experiments with similar results. *, p,0.05 (unpaired two-tailed t test);
**, p,0.01 (unpaired two-tailed t-test).
doi:10.1371/journal.ppat.1000329.g001
Author Summary
Maintenance of the cholesterol amount and transport
within cells are essential for healthy human cell functions.
Most bacteria do not need cholesterol, but certain bacteria
that infect human cells are dependent on host cell
cholesterol for their infection. How infected human cells
deal with these cholesterol-robbing bacteria, and in turn
how these bacteria hijack host cholesterol, are intriguing
questions. Anaplasma phagocytophilum is a bacterium that
lives inside white blood cells, and causes the disease
human granulocytic anaplasmosis (HGA). A. phagocytophi-
lum needs host cholesterol to live. Here, we discovered
that A. phagocytophilum infection increases the amount of
cholesterol in host cells and sequesters the majority of
cholesterol in A. phagocytophilum inclusions inside host
cells. Human cells acquire cholesterol from two sources:
receptor-mediated endocytosis of cholesterol-containing
low-density lipoprotein (LDL) from the circulating blood,
and synthesis of cholesterol inside the cells. Since A.
phagocytophilum depends on cholesterol derived from
LDL, it coaxes the host cell to take up more LDL by
increasing LDL receptor, through inhibition of LDL
receptor mRNA degradation. A. phagocytophilum infection
may serve as a model to improve our understanding of the
cellular cholesterol regulation in white blood cells, and
may provide insight regarding new therapeutic target for
treatment of HGA.
Anaplasma Modulation of LDL Uptake
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egress of free cholesterol occurs and free cholesterol is transported
to the plasma membrane or delivered to the ER. Excess free
cholesterol is catalyzed into cholesteryl esters by the resident ER
acyl-CoA: cholesterol acyltransferase and stored as cytoplasmic
lipid droplets [2,22].
Both undifferentiated and macrophage differentiated HL-60 cells
express a regulated LDLR [23]. Cholesterol is essential for A.
phagocytophilum infection in HL-60 cells [13]; thus, to better
understand the source of free cholesterol required for A. phagocyto-
philum infection, we first examined the LDLR-mediated cholesterol
uptake pathwayusing:1) lipoprotein-deficientserum(LPDS),2)anti-
LDLR monoclonal antibody (mAb), and 3) pharmacological
inhibitors of theLDLR-mediated cholesterol uptake pathway.LPDS
was prepared from the fetal bovine serum by removing ,95%
lipoproteins using potassium bromide gradient ultracentrifugation
(data not shown). The fractionated lipoprotein (LP) was added back
to LPDS in certain experiments. LPDS prevented the infection of
host cells by A. phagocytophilum, and LPDS reconstituted with LP
reversed this inhibition (Figure 3A). Moreover, the infection rate of
LPDS-conditioned HL-60 cells was decreased on day 2 p.i.
compared with that on day 1; and addition of LP rescued the
growth on day 2 p.i. (Figure 3A), suggesting that cholesterol derived
from LP is essential for A. phagocytophilum survival and proliferation in
host cells. LDL enters host cells via LDLR-mediated endocytosis,
which is blocked by a neutralizing antibody against LDLR [21]. We
found that the infection was also significantly blocked by the LDLR
mAb (Figure 3B).
U18886A and imipramine are hydrophobic amines that
accumulate in acidic cellular compartments, such as lysosomes,
and block the post-lysosomal transport of cholesterol in the LDL
uptake pathway [24,25]. We found that both U18886A and
Figure 2. Free cholesterol is enriched in A. phagocytophilum inclusions. A. phagocytophilum–infected HL-60 cells (A) and A. phagocytophilum
inclusions released from host cells (B) were fixed at 2 d p.i., stained with mouse anti-A. phagocytophilum (green) or normal mouse IgG and filipin
(blue), and analyzed by fluorescence microscopy. The experiment shown is representative of at least three independent experiments. Bar, 5 mm. Ap,
A. phagocytophilum.
doi:10.1371/journal.ppat.1000329.g002
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replication in HL-60 cells in a dose-dependent manner.
U18886A (5 mM) and imipramine (100 mM) added at 1 h p.i.
almost completely blocked bacterial growth (Figure 3C). In
contrast, lovastatin, an inhibitor of the rate-limiting enzyme 3-
hydroxy-3-methylglutaryl (HMG)-CoA reductase in the choles-
terol biosynthetic pathway [26], did not inhibit A. phagocytophilum
infection, but rather significantly enhanced it in HL-60 cells in a
dose-dependent manner (1–5 mM; Figures 3C and D). 25-
Hydroxycholesterol (25-HC), which inhibits both LDL uptake
and biosynthesis by acting as a negative feedback regulator of
cholesterol metabolism [27], partially inhibited A. phagocytophilum
infection (Figure 3C). Trypan blue and Diff-Quik staining
followed by light microscopy showed that although infected host
cells remained viable and did not show significant changes, the
morphological characteristics of A. phagocytophilum inclusions were
different: bacterial inclusions remained small in U18886A- or
imipramine-treated cells compared with those in untreated cells
(Figure 3D). The inhibitory effect of U18886A and imipramine, and
the stimulatory effect of lovastatin, were observed at 1 and 2 day p.i.
(Figure 3E).When inhibitorswere added at 1 dayp.i.(40%ofHL-60
cells were infected), the bacterial proliferation was still significantly
blocked in U18886A- and imipramine-treated cells at optimal
concentrations of 5 and 100 mM, respectively (Figure 3F). Taken
together, these results indicate that not only A. phagocytophilum
proliferation, but also survival of the bacterium in inclusions is
dependent on cholesterol derived from the LDL uptake pathway, as
bacterial numbers declined upon exposure to LPDS or imipramine.
Furthermore, de novo cholesterol biosynthesis is not required, and
inhibition of this biosynthesis stimulated, rather than inhibited A.
phagocytophilum infection in HL-60 cells. As A. phagocytophilum also
infects endothelial cells [10,11], we used another cell line, monkey
endothelial RF/6A to perform the inhibitor studies. Our data
showed that the infection of A. phagocytophilum in RF/6A was also
significantly inhibited by cholesterol transport inhibitors U18666A
(5 mM) and imipramine (20 mM). However, no inhibitory effect was
observedbylovastatintreatment(1 mM)(FigureS1).Takentogether,
these data suggest that LDLR-dependent cholesterol uptake
pathway is critical for A. phagocytophilum infection in both leukocytes
and endothelial cells.
DiI-LDL uptake is enhanced by A. phagocytophilum
infection in HL-60 cells
Our data have shown that total cellular free cholesterol is
increased in A. phagocytophilum–infected cells and that the LDL
uptake pathway is required for A. phagocytophilum infection. We thus
used LDL labeled with the fluorescent probe, 1, 19-dioctadecyl-3,
3, 39,3 9-tetramethyl indocarbocyanine (DiI–LDL) [28], to
compare the overall LDL uptake by A. phagocytophilum–infected
and uninfected HL-60 cells. We found that LDL uptake was
enhanced in A. phagocytophilum–infected cells (Figure 4C). After
dissociation from LDLR in early sorting endosomes, LDL is
directed to late endosomes for hydrolysis of cholesterol esters
[2,22]. By fluorescence microscopy, A. phagocytophilum inclusions
were surrounded by DiI-LDL-containing small vesicles (Figures 4A
and B), in agreement with our previous reports that lysosomes
accumulate around A. phagocytophilum inclusions [29].
LDLR mRNA and protein levels are elevated in A.
phagocytophilum–infected HL-60 cells
We next asked whether the increased cholesterol level and
enhanced LDL uptake of host cells upon A. phagocytophilum
infection may involve up-regulation of LDLR expression. First,
we compared mRNA levels of LDLR and other genes involved in
cholesterol and fatty acid biosynthesis, including HMG-CoA
reductase, HMG-CoA synthase, and fatty acid synthase [30] in
infected and uninfected HL-60 cells by real-time RT-PCR. As
shown in Figure 5A, LDLR mRNA level was significantly up-
regulated at least 4-fold at day 2 p.i. However, the expression of
cholesterol biosynthesis genes did not change significantly. The
fatty acid synthase gene was significantly down-regulated upon A.
phagocytophilum infection (Figure 5A). The pattern of LDLR mRNA
normalized to host cell TATA-box binding protein mRNA levels
was very similar to that normalized to G3PDH mRNA levels.
Second, we examined the LDLR protein level by western blotting.
As shown in Figure 5B, LDLR was markedly up-regulated upon A.
phagocytophilum infection. To evaluate whether new protein
synthesis or intracellular proliferation of A. phagocytophilum is
required for LDLR mRNA up-regulation, 10 mg/ml of oxytetra-
cycline was added to cell cultures at 1 h p.i. This treatment
completely blocked bacterial proliferation as confirmed by Diff-
Quik staining (data not shown) and western blotting using mAb
5C11 against the A. phagocytophilum major surface protein, P44
(Figure 5C inset). LDLR mRNA up-regulation at day 2 p.i. was
abolished by oxytetracycline treatment (Figure 5C), suggesting that
synthesis of new A. phagocytophilum proteins and/or intracellular
proliferation is required to induce LDLR mRNA up-regulation in
HL-60 cells. Notably, real-time RT-PCR analysis showed that
LDLR mRNA levels in A. phagocytophilum–infected HL-60 cells
were significantly increased by lovastatin treatment in a dose-
dependent manner (Figure 5D). Western blotting also showed that
the LDLR level was markedly higher in lovastatin-treated HL-60
cells at day 2 p.i. compared to DMSO–treated control cells
(Figure 5E), which may explain the enhanced infection level in the
lovastatin-treated sample as shown in Figure 3. Taken together,
these results show that A. phagocytophilum infection enhances LDL
uptake by up-regulating LDLR expression.
SREBP cleavage is not involved in the up-regulation of
LDLR mRNA in A. phagocytophilum–infected HL-60 cells
Sterol regulatory element binding proteins (SREBPs) are key
transcription factors for the cholesterol-mediated feedback regula-
tion to maintain intracellular cholesterol homeostasis by regulating
the LDLR gene as well as many cholesterol biosynthesis genes [3].
Three SREBP isoforms have been characterized, namely SREBP-
1a, SREBP-1c and SREBP-2 [31]. SREBP-1c, the predominant
isoform in adult liver, preferentially activates genes required for fatty
acid synthesis, whereas SREBP-2 preferentially activates the LDLR
gene and various genes required for cholesterol synthesis, such as
HMG-CoA reductase [32]. Therefore, we investigated whether the
up-regulation of LDLR by A. phagocytophilum infection was due to
activation of SREBP-2. SREBPs are activated by cleavage and
translocation of the cleaved product from the cytoplasm to the
nucleus [3]. As shown in Figures 6, mature cleaved SREBP-2 levels
remained unchanged throughout A. phagocytophilum infection. As a
positive control for SREBP-2 cleavage, uninfected cells were
incubated with LPDS-conditioned medium overnight, as this is
known to induce SREBP-2 cleavage in different cell lines including
CHO and human monoblastic leukemia cell line U937 [33]. There
was no significant difference between A. phagocytophilum–infected and
uninfected HL-60 cells at any post-infection time point examined,
suggesting that SREBP-2 activation is not involved in the up-
regulation of LDLR mRNA upon A. phagocytophilum infection in HL-
60 cells. In another word, the dramatic intracellular cholesterol
homeostasis up-shift by A. phagocytophilum infection cannot be sensed
by the host cell key regulatory factor SREBP-2.
Anaplasma Modulation of LDL Uptake
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phagocytophilum–induced LDLR mRNA up-regulation
LDLR is regulated not only at the transcriptional level but also
at the posttranscriptional level via modulation of LDLR mRNA
stability [34]. Therefore, we investigated LDLR mRNA stability in
A. phagocytophilum–infected HL-60 cells after treatment with
actinomycin D, a eukaryotic DNA-dependent RNA polymerase
inhibitor. The half-life of LDLR mRNA in infected HL-60 cells
was increased by almost 2-fold as compared to uninfected cells
(Figure 7A). In contrast, the stability of HMG-CoA reductase
mRNA did not change noticeably during A. phagocytophilum
infection (Figure 7B). Human LDLR mRNA contains a 2.5-kb
39UTR [35]. The 39UTR of LDLR mRNA can be stabilized by
phorbol-12-myristate-13-acetate (PMA) and a Chinese herbal
compound, berberine in the human hepatic cell line HepG2
[36,37]. Three AU-rich elements (AREs) are located in the 59
proximal region of the 39UTR, which have been shown to be
responsible for the stabilization of LDLR mRNA by berberine, but
not by PMA [37]. To investigate whether the LDLR 39UTR
containing three AREs is involved in A. phagocytophilum–induced
LDLR stabilization, we transfected the luciferase fusion plasmid
pLuc/LDLR 39UTR-2, containing three AREs of LDLR 39UTR
Figure 4. DiI-LDL uptake is enhanced upon A. phagocytophilum infection in HL-60 cells. Uninfected and A. phagocytophilum–infected HL-60
cells were incubated with increasing concentrations of DiI-LDL at 37uC for 2 h. After DiI-LDL uptake, HL-60 cells were directly observed by
fluorescence microscopy without fixation (A), or after being fixed and labeled with anti–A. phagocytophilum (B). Arrows indicate A. phagocytophilum
inclusions. Ap, A. phagocytophilum. The amount of cell-associated DiI was determined by fluorometric assay. Data were normalized to total cellular
protein, and specific association was determined by subtracting the fluorescence measured in the presence of a 30-fold excess concentration of
unlabeled LDL from normalized cell-associated DiI fluorescence (C). Data are expressed as mean6standard deviation (n=3) and are representative of
two independent experiments. *, p,0.05 (unpaired two-tailed t test); **, p,0.01 (unpaired two-tailed t-test).
doi:10.1371/journal.ppat.1000329.g004
Figure 3. A. phagocytophilum infection requires cholesterol derived from the host LDL uptake pathway rather than de novo
biosynthesis. (A) A. phagocytophilum growth in HL-60 cells cultured in the growth medium containing lipoprotein deficient serum (LPDS), LPDS
reconstituted with lipoproteins (LP), and fetal bovine serum were determined on days 1 and 2 p.i. (B) HL-60 cells were pre-treated with anti-LDLR
mAb and isotype control mouse IgG and infected with host cell–free A. phagocytophilum. The number of bacteria was determined on days 3 and 4 p.i.
(C) Cholesterol transport and biosynthesis inhibitors U18886A, imipramine, 25-hydroxycholesterol (25-HC), and lovastatin were added at 1 h p.i. at
different dosages, and numbers of bacteria were determined on day 2 p.i. Data are expressed as mean6standard deviation (n=3) and are
representative of two independent experiments with similar results. *, p,0.05 (unpaired two-tailed t test); **, p,0.01 (unpaired two-tailed t-test). (D)
A. phagocytophilum-infected HL-60 cells at 1 h p.i. were treated with lovastatin (1 mM), U18886A (1 mM), imipramine (20 mM), and DMSO vehicle
control, respectively. On day 1 p.i., infected cells were harvested and observed by light microscopy following Diff-Quik staining. Arrows indicate A.
phagocytophilum inclusions. Note much smaller sizes of inclusions that contain much fewer numbers of bacteria in U18886A- or imipramine-treated
cells than those in untreated or lovastatin-treated cells. N, nucleus. All figures are shown at the same magnification. Bar, 5 mm. (E) Cultures were
treated as in (C), and numbers of bacteria were determined on days 1 and 2 p.i. *, p,0.05 (unpaired two-tailed t test); **, p,0.01 (unpaired two-tailed
t-test). (F) Lovastatin (1 mM), U18886A (5 mM), imipramine (100 mM), and vehicle control were added to A. phagocytophilum-infected HL-60 on day 1
p.i. (,40% infected cells), and the number of bacteria was determined on day 2 p.i. Data are expressed as mean6standard deviation (n=3) and are
representative of three independent experiments with similar results. *, p,0.05 (unpaired two-tailed t test); **, p,0.01 (unpaired two-tailed t-test).
doi:10.1371/journal.ppat.1000329.g003
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luciferase mRNA levels in A. phagocytophilum–infected and control
RF/6A cells. As shown in Figure 7C, luciferase mRNA levels
normalized to the antibiotic zeocin resistance gene (plasmid copy
number) were significantly increased in A. phagocytophilum–infected
cells. Data normalized by G3PDH (host cell number) showed a
similar pattern (data not shown). These results indicate that the
LDLR 39UTR containing three AREs may be involved in
enhancing LDLR mRNA stability in A. phagocytophilum–infected
host cells.
Figure 5. LDLR is up-regulated in A. phagocytophilum–infected HL-60 at transcriptional and protein levels. (A) At day 2 p.i., total RNA
was extracted from uninfected and A. phagocytophilum–infected HL-60 cells. Analysis of mRNA amount was performed using quantitative RT-PCR
with specific primers for each gene. Transcript levels were normalized to mRNA level of TATA-box binding protein or G3PDH in each sample. Ap, A.
phagocytophilum. (B) Cell samples were collected at the indicated time points, membrane fractions were isolated, and western blotting was
performed to determine LDLR protein levels in uninfected HL-60 and A. phagocytophilum–infected HL-60 cells. (C) Oxytetracycline (OTC, 10 mg/ml)
was added to A. phagocytophilum–infected HL-60 cells at 1 h p.i., RNA was extracted from infected HL-60 cells on days 1 and 2 p.i., and LDLR mRNA
was analyzed by quantitative RT-PCR. Transcript levels were normalized to mRNA level of TATA-box binding protein in each sample. Inset shows
western blotting result using mAb 5C11 against A. phagocytophilum major surface protein P44. (D) Relative LDLR mRNA in lovastatin-treated cell
cultures on day 2 p.i. was analyzed by quantitative RT-PCR with primers specific for LDLR gene. (E) LDLR protein levels in lovastatin- or mock (DMSO)-
treated infected cells at day 2 p.i. were analyzed by western blotting using anti-LDLR mAb. Data are expressed as mean6standard deviation (n=3)
and are representative of two independent experiments. *, p,0.05 (unpaired two-tailed t test); **, p,0.01 (unpaired two-tailed t-test).
doi:10.1371/journal.ppat.1000329.g005
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expression, is required for A. phagocytophilum infection
Accumulating evidence suggests that the extracellular signal–
regulated kinase (ERK) signaling cascade regulates the induction
of LDLR expression in HepG2 cells [34,38]. Moreover, berberine
increases LDLR expression at the posttranscriptional level via
ERK-dependent stabilization of LDLR mRNA [37]. Therefore,
we asked whether and when ERK1/2 (p44/p42) is activated
during A. phagocytophilum infection, whether ERK1/2 activation is
required for A. phagocytophilum infection, and whether ERK1/2
activation up-regulates LDLR, constituting a positive feedback
loop for A. phagocytophilum replication. First, we determined
whether ERK1/2 is activated by A. phagocytophilum infection in
HL-60 cells by western blotting using an antibody that only
recognizes activated (phosphorylated) ERK1/2 but not inactive
ERK1/2, as well as an antibody that recognizes both unpho-
sphorylated and phosphorylated forms of ERK. We found that A.
phagocytophilum activated ERK signaling especially during the
exponential growth stage (day 2 p.i.) compared to day 1 p.i. or
uninfected HL-60 cells (Figure 8A). Second, we examined the
effect of U0126, the inhibitor of ERK upstream kinase MEK1/2,
on ERK activation upon A. phagocytophilum infection. ERK
activation by A. phagocytophilum infection and A. phagocytophilum
replication in HL-60 cells were also almost completely inhibited by
10 mM U0126 (Figures 8A and B). This result was confirmed by
western blotting for A. phagocytophilum P44 (Figure 8C). To confirm
ERK activation is required for A. phagocytophilum infection, MEK1/
2 proteins were knocked down by RNA interference with siRNAs
targeting the MEK1 and MEK2 genes. Results showed that at 4
days post transfection, the protein amount of MEK1/2 was
reduced by ,40% in MEK1/2 knockdown group, which resulted
in the partial inhibition of the phosphorylation of ERK1/2
(,30%), as well as the infection of A. phagocytophilum
(,50%)(Figure 8D). These data clearly demonstrate that ERK
signaling is activated by and required for A. phagocytophilum
infection in HL-60 cells.
To determine whether ERK activation is involved in up-
regulation of LDLR upon A. phagocytophilum infection, we
examined the LDLR mRNA levels in U0126-pretreated HL-60
cells by real-time RT-PCR. As shown in Figure 8E, the relative
LDLR mRNA level upregulated by A. phagocytophilum–infected
HL-60 cells was significantly reduced by U0126 treatment starting
at a concentration of 0.5 mM at 2 day p.i. Although the expression
of LDLR mRNA was slightly reduced in uninfected HL-60 cells by
MEK1/2 siRNA knockdown, there was no significant reduction of
LDLR mRNA in infected HL-60 cells (data not shown).
Therefore, we could not draw the definitive conclusion whether
MEK1/2RERK1/2 pathway is required for up-regulation of
LDLR expression in the case of A. phagocytophilum infection of HL-
60 cells.
Discussion
In this study, we present evidence that A. phagocytophilum is
dependent on cholesterol derived from the LDLR-mediated
uptake pathway of eukaryotic host cells. Several vacuole-
occupying intracellular pathogens depend on host cholesterol
Figure 6. SREBP activation is not up-regulated in Anaplasma
phagocytophilum–infected HL-60 cells. Uninfected and A. phagocy-
tophilum–infected HL-60 cells were collected at the indicated time
points, and western blotting was performed using anti-SREBP-2 mAb. a-
Tubulin was used as the protein input control to normalize each
sample. Positive control was set up by incubating uninfected cells with
LPDS-conditioned medium overnight. Ratio of band intensities of
mature form to precursor form of SREBP was calculated to show the
SREBP-2 cleavage. Data are representative of three independent
experiments. Ap, A. phagocytophilum. P, precursor form of SREBP; M,
mature form of SREBP.
doi:10.1371/journal.ppat.1000329.g006
Figure 7. LDLR mRNA is stabilized in A. phagocytophilum–
infected host cells. Actinomycin D (5 mg/ml) was added to uninfected
and A. phagocytophilum–infected HL-60 cells for different periods. Total
RNA was isolated, and LDLR mRNA (A) and HMG-CoA reductase mRNA
(B) were analyzed by quantitative RT-PCR. Data are expressed as
mean6standard deviation (n=3) and are representative of two
independent experiments. The decay rates of LDLR mRNA (A) are
significantly different (p,0.01), as tested by two-way ANOVA. (C)
Chimeric pLuc/LDLR 39UTR-2 was transfected into RF/6A cells using
FuGene HD reagent, and host cell–free A. phagocytophilum was added
to transfected RF/6A cells at 1 day post transfection. Luc mRNA was
analyzed on day 2 p.i. by quantitative RT-PCR. Cell samples were
normalized by the antibiotic gene zeocin mRNA level. Data are
representative of two independent experiments. Ap, A. phagocytophi-
lum. ND, not detectable. **, p,0.01 (unpaired two-tailed t-test).
doi:10.1371/journal.ppat.1000329.g007
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[5], although mechanisms vary considerably. Salmonella enterica
serovar Typhimurium requires nonsterol precursors of the
cholesterol biosynthetic pathway for intracellular proliferation
[39], and cholesterol accumulates in Salmonella-containing vacuoles
in a Salmonella pathogenecity island-2–dependent manner [8,40].
The establishment of Brucella abortus infection in mice requires
trafficking of plasma membrane cholesterol, which is controlled by
Niemann-Pick C1, an important cholesterol transport protein in
late endosomes/lysosomes, as evidenced by resistance to B. abortus
infection in Niemann-Pick C1 knockout mice [6]. Chlamydia
trachomatis inclusions acquire cholesterol by selectively rerouting
Golgi-derived vesicles [41] and multivesicular bodies [42].
Interestingly, cytoplasmic lipid droplets are translocated into the
lumen of Chlamydia inclusions, which appears to be an alternate
mechanism for acquisition of cholesterol [43]. Coxiella burnetii
infection increases production of host cell cholesterol with
concomitant up-regulation of host genes involved in cholesterol
metabolism, including LDLR and several cholesterol biosynthesis
genes [7]. Unlike any of the above described intracellular
pathogens, A. phagocytophilum acquires cholesterol preferentially
from the LDL uptake pathway by up-regulating LDLR expression.
Toxoplasma gondii, although a eukaryotic pathogen, cannot
synthesize sterols via the mevalonate pathway and appropriates
cholesterol to its parasitophorous vacuole exclusively from LDL
uptake [44]. Recently, an unexpected novel mechanism was
demonstrated: T. gondii actively sequesters the host endocytic
vesicles in its vacuolar spaces to provide its cholesterol needs [45].
Interestingly, A. phagocytophilum has an intracellular compartment
somewhat similar to that of T. gondii [29,46], which is segregated
from both endocytic and exocytic pathways.
Figure 8. ERK signaling pathway is involved in the LDLR up-
regulation upon A. phagocytophilum infection. (A) Western blot
analysis was performed using antibodies specific to either the
phosphorylated or total ERK1/2. Uninfected and A. phagocytophilum–
infected HL-60 cells with or without 10 mM ERK inhibitor U0126
treatment were collected at the indicated time points. a-Tubulin was
used as the protein loading control to normalize each sample. The
values under the bands show the ratios of band intensities of p-ERK and
ERK. Ap, A. phagocytophilum. (B) Bacterial numbers per 100 cells treated
with the indicated concentrations of U0126 were determined on days 1
and 2 p.i. (C) Western blot analysis of A. phagocytophilum–infected HL-
60 cells on day 2 p.i. treated with the indicated concentrations of U0126
was performed using antibodies specific to phosphorylated or total
ERK1/2, or A. phagocytophilum outer membrane protein P44. a-Tubulin
was used as the protein input control to normalize each sample. The
values under the bands show the ratios of band intensities of p-ERK and
P44, normalized to total ERK or a-tubulin, respectively. Data are
representative of three independent experiments. (D) HL-60 cells were
transfected with control (Ctl) or double-stranded siRNA specific
targeting the genes encoding MEK1 and MEK2 (MEK1+2) (3 mg/2610
6
cells) using the Amaxa Nucleofection system. Two days after
transfection, host cell-free A. phagocytophilum was added to the cells
and incubated for additional 2 days. One aliquot of samples were lysed
and subjected to Western blotting using antibodies against MEK1/2,
ERK1/2, phospho-ERK1/2, and A. phagocytophilum P44 protein. The
relative protein amount of MEK1/2, phospho-ERK1/2, and P44 were
determined using total ERK1/2 as loading control by densitometry
analysis. The values under the bands show the relative ratios of band
intensities, with the ratios of those from samples nucleofected with
control siRNA arbitrarily set as 1. Results are representative of three
independent experiments. (E) LDLR expression in A. phagocytophilum–
infected HL-60 cells on day 2 p.i. treated with the indicated
concentrations of U0126 was determined by quantitative RT-PCR. Data
are expressed as mean6standard deviation (n=3) and are representa-
tive of two independent experiments. *, p,0.05 (unpaired two-tailed t
test); **, p,0.01 (unpaired two-tailed t-test).
doi:10.1371/journal.ppat.1000329.g008
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phagocytophilum acquire cholesterol derived from the host LDL
endocytic pathway? Although A. phagocytophilum inclusions do not
fuse with lysosomes, our previous data clearly demonstrate that
these inclusions are surrounded by host lysosomes [29]. The
physical proximity between the A. phagocytophilum inclusions and
host lysosomes may facilitate cholesterol acquisition by A.
phagocytophilum. Not only A. phagocytophilum enters host cells via
caveolae-containing lipid rafts, but also the caveolar marker
protein, caveolin-1, co-localizes with both early and replicative A.
phagocytophilum inclusions [13]. Caveolin-1 is a well-established
cholesterol binding protein [47], and caveolae/caveosomes have
been proposed to be a cholesterol transporter participating in the
bidirectional shuttling of free cholesterol between the plasma
membrane and various intracellular compartments, including the
ER, Golgi and lipid droplets [48]. Therefore, we hypothesize that
the caveosome is involved in cholesterol transport to A.
phagocytophilum inclusions. Another finding showed that some A.
phagocytophilum inclusions co-localize with vesicle-associated mem-
brane protein 2 (VAMP2) [29]. In neutrophils, VAMP2 is believed
to play a role in controlling vesicular targeting, docking, and fusion
through interactions with other proteins, such as N-ethylmalei-
mide-sensitive factor and soluble N-ethylmaleimide-sensitive factor
attachment protein [49]. The presence of VAMP2 on A.
phagocytophilum inclusions may provide a mechanism to acquire
cholesterol for the replicating organism through regulated vesicle
trafficking. A recent report showed that A. phagocytophilum
modulates lipid metabolism by increasing perilipin mRNA and
protein levels to facilitate infection of HL-60 cells [50]. Perilipin is
a major adipocyte lipid droplet–associated protein that plays a
central role in lipolysis and cholesterol synthesis. It is unknown
whether lipid droplets serve as an intermediate organelle for
cholesterol acquisition by A. phagocytophilum after intracellular
delivery via the LDLR pathway. Further work is required to
determine the exact mechanism of cholesterol acquisition by A.
phagocytophilum.
Our data demonstrate that A. phagocytophilum up-regulates
LDLR expression in HL-60 cells by stabilizing the LDLR mRNA
via a posttranscriptional mechanism. This is the first report on
modulation of LDLR mRNA stability by an infectious agent, and
to our knowledge this is also the first report regarding LDLR up-
regulation on leukocytes. This aspect may have clinical relevance
because increasing hepatic LDLR expression is currently one of
the primary strategies for hypercholesterolemia therapy. Recent
data suggest that mRNA stability is the major mode of
posttranscriptional regulation of LDLR expression. The stability
of LDLR mRNA is known to be modulated by only a few
reagents, including gemfibrozil [51], PMA, chenodeoxycholic acid
and berberine [34]. Interestingly, the stabilization of LDLR
mRNA via the 39UTR by chenodeoxycholic acid (CDCA) and
berberine requires activation of the ERK signaling pathway.
However, it is so far unclear how the ERK pathway is linked to
LDLR mRNA stabilization and whether any trans-acting RNA
binding proteins are involved in the stabilization process. In
addition, the activity of berberine to up-regulate LDLR expression
is specific to hepatocytes, as the significant increase of LDLR was
found only in HepG2 cells, but not in other non-hepatic cell lines,
such as CHO, HEK293, or human primary fibroblasts [52]. The
present study shows that A. phagocytophilum potently activates the
ERK signaling pathway, especially at the exponential growth stage
when the bacterium requires substantial amounts of cholesterol for
proliferation with concomitant expansion of inclusions. The result
is somewhat consistent with the recent report that A. phagocytophilum
activates ERK2 (p42) in host human neutrophils at 3 h p.i. [53].
For the first time, our MEK inhibitor and siRNA knock-down
studies showed ERK activation is required for A. phagocytophilum
infection. It has been reported that several other intracellular
bacteria actively manipulate the host ERK signaling pathway to
benefit microbial survival. Tapinos and Rambukkana reported a
PKCe-dependent, but not MEK-dependent pathway for ERK1/2
activation by Mycobacterium leprae resulting in continuous prolifer-
ation of infected human Schwann cells, without inducing
transformation [54]. Interestingly, activation of the host Ras-
Raf-MEK-ERK-cPLA2 signaling cascade is required for chla-
mydial acquisition of host glycerophospholipids [55]. It remains to
be elucidated why ERK activation is required for A. phagocytophilum
infection or whether ERK involves in LDLR mRNA stabilization.
Recently, the use of cholesterol biosynthesis inhibitors, such as
statins, was proposed to combat certain pathogen infections because
these microbes utilize the host cholesterol biosynthesis pathway. For
example, lovastatin and atorvastatin reduce S. enterica serovar
Typhimurium proliferation in vitro and in BABL/C mice,
respectively [39]. Growth of C. burnetii can be also inhibited by
lovastatin in vitro [7]. It is important to point out that unlike
Salmonella and Coxiella, lovastatin enhanced, at least, did not reduce
A.phagocytophiluminfectioninbothHL-60promyelocyticandRF/6A
endothelial cells. This result is not surprising, however, because our
present data show that A. phagocytophilum acquires cholesterol derived
from the LDL uptake pathway and not from the biosynthesis
pathway. Additionally, lovastatin-treated A. phagocytophilum–infected
HL-60 cells expressed higher levels of LDLR. Thus, the question
then becomes: is statin treatment beneficial, if not detrimental for A.
phagocytophilum infection in vivo? The answer to this question is very
important because statin drugs are widely used in elderly patients to
treat hypercholesterolemia, and A. phagocytophilum infection is more
prevalent in this community. Our recent data showed that high
blood cholesterol facilitates A. phagocytophilum infection in a mouse
model [14]. However, our unpublished data suggest that there is a
higher A. phagocytophilum level in the blood after Lipitor (atorvastatin)
treatment of mice (Xueqi Wang and Yasuko Rikihisa, unpublished
data). We had originally hypothesized that statin treatment lowers
blood cholesterol levels and consequently results in lower bacterial
burden in the mice. This paradox could be explained as follows:
statins do not reduce overall plasma cholesterol levels in mice, as
they do in humans, due to very low levels of LDLs in rodents, even
though they do block mouse HMG-CoA reductase and the sterol
biosynthetic pathway in mice [56]. In fact, we have not found
decreased blood cholesterol levels in statin-treated mice (Xueqi
Wang and Yasuko Rikihisa, unpublished data). Similarly, there is no
significant change in serum cholesterol levels in atorvastatin-treated
mice compared with vehicle-treated mice, although statins reduce S.
enterica serovar Typhimurium growth in vivo [39]. Therefore, we
speculate that, similar to our in vitro HL-60 cell culture model, up-
regulation of LDLR in A. phagocytophilum–infected host leukocytes
may result in a greater bacterial burden in statin-treated mice.
Taken together, these results suggest that critical and careful
consideration is required when treating granulocytic anaplasmosis
patients, as statins are currently widely used to treat hypercholes-
terolemia in humans by lowering blood cholesterol levels.
The data presented here improve our understanding of how a
cholesterol-dependent bacterium exploits eukaryotic cellular
cholesterol trafficking and regulatory pathways and may provide
insight regarding a new therapeutic target for the treatment of
human granulocytic anaplasmosis. Most information on LDLR
regulation is derived from studies using hepatocytes [34]; however,
as in the berberine’s case [52], in non-hepatic cells, LDLR
regulation by cholesterol modulating compounds may differ from
those of hepatocytes. Our study enhances our understanding of the
Anaplasma Modulation of LDL Uptake
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Filipin, lovastatin, imipramine and U18666A were obtained
from Sigma (St. Louis, MO). 25-Hydroxycholesterol (25-HC) was
purchased from Steraloids, Inc. (Newport, RI). MAPK inhibitor
U0126 was obtained from Biomol (Plymouth Meeting, PA). DiI-
LDL and native LDL were purchased from Molecular Probes
(Eugene, OR) and Intracel, Inc. (Frederick, MD), respectively.
The mouse mAb 5C11 recognizing the N-terminal conserved
region of A. phagocytophilum major surface protein P44 has been
described [57]. The anti-LDLR mAb was purified from the
supernatant of hybridoma ATCC CRL-1691 (C7) grown in
advanced MEM (ATCC, Manassas, VA) by affinity chromatog-
raphy using HiTrap Protein G HP (GE Healthcare, Piscataway,
NJ) according to the manufacturer’s instructions. The purity of the
antibody was confirmed by SDS-PAGE followed by GelCode Blue
staining (Pierce, Rockford, IL). Other antibodies used include:
mouse anti-SREBP-2 mAb (BD Parmingen, San Jose, CA), mouse
anti-phospho-ERK1/2 mAb, rabbit anti-ERK1/2 antibody,
mouse anti-MEK1/2 mAb (Cell Signaling, Danvers, MA), and
mouse anti-a-tubulin mAb (Santa Cruz Biotechnology, Santa
Cruz, CA). Peroxidase-conjugated secondary antibodies were
obtained from KPL (Gaithersburg, MD). Normal mouse IgG
were purchased from Santa Cruz Biotechnology.
Preparation of LPDS and lipoproteins
LPDS was prepared from fetal bovine serum (Mediatech, Inc.,
Herndon, VA) by gradient ultracentrifugation after density
adjustment by solid KBr as described [58,59]. LPs were used to
supplement LPDS, as necessary for certain experiments. LPDS
and LP fractions were dialyzed at least 36 h against buffer
containing 0.15 M NaCl and 0.3 mM EDTA, pH 7.4. The
volume of each fraction was adjusted to be equivalent to that of the
original serum, and the cholesterol concentration of each fraction
was measured by Infinity
TM cholesterol reagent kit (Thermo
Electron Corp., Louisville, CO).
A. phagocytophilum culture and inhibitor treatments
A. phagocytophilum HZ strain was cultivated in human promy-
elocytic leukemia cell line HL-60 as described [60]. Host cell-free
A. phagocytophilum was prepared by sonicating highly infected
(.90% infected cells) HL-60 cells for 8 s twice at an output setting
of 2 with an ultrasonic processor (W-380; Heat Systems, Farm-
ington, NY). After low-speed centrifugation to remove nuclei and
unbroken cells, the supernatant was centrifuged at 10,0006g for
10 min, and the pellet enriched with host cell–free organisms was
added to HL-60 or RF/6A cells. After 1 h incubation at 37uC,
extracellular organisms were washed, fresh medium was added
(this time point was considered 0 h p.i.), and continuously
incubated at 37uC.
Inhibitors were added at indicated time points (0 h or 1 day p.i.),
and the inhibitors were kept in the growth media throughout the
incubation period or removed later as indicated. The highest final
concentrations of inhibitors used were: lovastatin (5 mM), imipra-
mine (100 mM), U18666A (5 mM), and 25-HC (25 mM). Inhibitor
treatmentsat these concentrationsdid not affecthostcell integrity as
assessed by light microscopy or by G3PDH mRNA level. For LPDS
treatment, 10% LPDS or LP-reconstituted LPDS conditioned
growth medium was added at 0 h p.i. in place of the growth
medium containing 10% fetal bovine serum. To block LDLR
function, HL-60 cells were pretreated with anti-LDLR (IgG2b; final
concentrations:20 mg/ml) or IgG2b isotype control antibody at 4uC
for 1 h followed by addition of host cell–free bacteria, and then
culture was continued at 37uC for the indicated times.
The degree of bacterial infection in host cells was assessed by
Diff-Quik staining (Baxter Scientific Products, Obetz, OH), and
the number of A. phagocytophilum cells was estimated in 100 host
cells in triplicate culture wells as described [61].
Cholesterol assay of infected cells
Uninfected and A. phagocytophilum–infected HL-60 cells at the
indicated timepoints (1 h, 1 day, 2 day and 3 day) were collected, and
total cellular cholesterol levels were measured by an Amplex Red
cholesterol assay kit (Molecular Probes) as described [13]. The total
cholesterol content was normalized by the total protein concentration
as determined by bicinchoninic acid reagent (Pierce).
DiI-LDL uptake assay
DiI-LDL uptake by infected and uninfected HL-60 cells was
measured by the modified method of Teupser et al. [62]. Briefly,
uninfected and approximately 40% infected HL-60 cells were
incubated with LPDS-conditioned medium for 12 h to enhance
LDLR expression. Then, increasing concentrations of DiI-LDL (2,
5, 10 mg protein/ml) with or without 30-fold excess of unlabeled
LDL were added to HL-60 cells and incubated for 2 h at 37uC.
The cells were thoroughly washed with phosphate-buffered saline
(PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and
2m MK H 2PO4, pH 7.4) containing 0.4% bovine serum albumin,
and lysed in the lysis reagent (0.1% SDS/0.1 N NaOH) for 1 h
with gentle shaking. Cellular uptake of DiI-LDL was measured in
a fraction (200 ml) of the lysate by fluorescence spectroscopy with
excitation and emission wavelengths of 520 and 580 nm,
respectively. The fluorometric data were normalized by the total
protein content.
Filipin staining and immunofluorescence microscopy
Filipin staining was performed as described by Millard et al
[63]. Cells were fixed in 4% paraformaldehyde at room
temperature for 15 min and incubated with 50 mg/ml filipin in
PBS/10% normal sheep serum for 30 min at room temperature.
Then the cells were incubated with mouse anti–A. phagocytophilum
antiserum in filipin/PBS/10% normal sheep serum for 60 min at
37uC followed by incubation with fluorescence-conjugated sec-
ondary antibodies for 30 min. Normal mouse antibodies were used
as negative controls. Cells were then washed and observed under a
Nikon Eclipse E400 fluorescence microscope with a xenon-
mercury light source (Nikon Instruments, Melville, NY).
Western blot analysis
A. phagocytophilum–infected HL-60 and control HL-60 cells
(2610
6) were washed and resuspended in 100 ml PBS containing
freshly added protease inhibitor cocktail set III and phosphatase
inhibitor cocktail set II (Calbiochem, San Diego, CA), and lysed by
mixing with 100 mlo f2 6Laemmli sample buffer (4% SDS,
135 mM Tris-HCl [pH 6.8], 20% glycerol, and 10% b-mercap-
toethanol). Samples were separated by SDS-PAGE with 7.5% or
10% polyacrylamide resolving gels and then transferred to a
nitrocellulose membrane using a semidry blotter (WEP, Seattle,
WA). The membrane was blocked using 5% (wt/vol) skim milk
(Kroger, Cincinnati, OH) in Tris-buffered saline (150 mM NaCl
and 50 mM Tris at pH 7.5) containing 0.1% Tween-20,
incubated with primary antibodies (1:500 or 1:1,000 dilution) at
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conjugated secondary antibodies at 1:1,000 dilution at room
temperature for 1 h. Immunoreactive bands were visualized with
enhanced chemiluminescence. To detect LDLR protein amount,
the membrane fraction of cells was prepared according to Holla et
al. [64], and Western blotting was carried out as described [65].
Quantitative RT-PCR
Uninfected and A. phagocytophilum–infected HL-60 cells were
harvested, and RNA was isolated using the RNeasy kit (Qiagen,
Valencia, CA). Total RNA (2 mg) was reverse transcribed using
SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA)
and oligo(dT)12–18 primer (Invitrogen). Quantitative PCR (20 ml
total volume) was performed with 1 ml of cDNA (corresponding to
0.2–0.4 mg of total RNA) and 0.25 mM of each primer using a
SYBR Green PCR kit (Stratagene, La Jolla, CA) in a Mx3000P
Real-time PCR system (Stratagene). All primers for cholesterol-
related genes were described in Castoreno et al. [30] and G3PDH
primers were described in Zhang et al. [66].
Transfection of RF/6A cells and quantitative RT-PCR
analysis of Luc transcript
The chimeric plasmid pLuc/LDLR 39UTR-2 has been
described [37]. The constructs were sequenced, and individual
clones were propagated to isolate plasmid DNA using the
Endofree plasmid maxi kit (Qiagen). The plasmids were
transfected into endothelial cells, RF/6A, using the FuGene
transfection reagent (Roche, Indianapolis, IN). After 24 h, host
cell–free A. phagocytophilum purified from highly infected HL-60
cells were inoculated into transfected RF/6A cells and incubated
for additional 24–48 h. Samples were collected, and first-strand
cDNA was synthesized as described above following DNase I
(Invitrogen) treatment. The Luc transcripts were measured by
quantitative real-time RT-PCR using specific primers: forward,
TCCAACCCGGTAAGACACGACT, and reverse, TCAGCA-
GAGCGCAGATACCAAATA. Host cell G3PDH and the
plasmid antibiotics gene zeocin (forward, GACGACGT-
GACCCTGTTCATCAGC; reverse, CACTCGGCGTA-
CAGCTCGTCCAG) were used for normalization.
RNA interference
HL-60 cells were transfected with double-stranded siRNA
(3 mg/2610
6 cells) using the Amaxa nucleofection system (kit V,
program T-19; Lonza/Amaxa Inc, Walkersville, MD) as described
previously [67]. Verified human-specific siRNAs targeting the
genes encoding MEK1 (siRNA ID: s11167) and MEK2 (siRNA
ID: s11170), or control siRNA (# 4390843) not targeting any
known human genes were purchased from Ambion (Applied
Biosystems/Ambion, Austin, TX). Two days after transfection,
host cell-free A. phagocytophilum was added to cells and incubated for
additional 2 days. Samples were then harvested and divided into
two aliquots. One group of samples was lysed in M-PER lysis
buffer (Pierce) supplemented with protease and phosphatase
inhibitor cocktail (Calbiochem), and subjected to Western blotting
using antibodies against MEK1/2, ERK1/2, phospho-ERK1/2
and A. phagocytophilum P44 outer membrane protein [58]. Images
were then captured and densitometric analysis was performed
using LAS3000 image documentation system (FUJIFILM Medical
Systems USA, Stamford, CT). The other aliquots were stored in
RNALater for further quantitative real-time RT-PCR analysis as
described above.
Statistical analysis
Statistical analyses were performed by unpaired, 2-tailed
Student’s t-test. Two-way ANOVA was used to compare mRNA
decay rates. p,0.05 was considered to be significant.
Supporting Information
Figure S1 Cholesterol transport and biosynthesis inhibitors
U18886A, imipramine, and lovastatin were added into RF/6A
cells at 3 h p.i. at the indicated dosages, and infection percentage
(A) and numbers of bacteria (B) were determined on day 3 p.i..
Data are expressed as mean6standard deviation (n=3) and are
representative of three independent experiments with similar
results. **, p,0.01 (unpaired two-tailed t-test).
Found at: doi:10.1371/journal.ppat.1000329.s001 (0.04 MB PDF)
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